NucleoTIDE and PepTIDE Drug Discovery Center | INSTITUTE OF SCIENCE TOKYO

TIDE is exploring the boundaries of drug discovery through innovation

The NucleoTIDE and PepTIDE Drug Discovery Center (TIDE Center) is a multidisciplinary community of researchers to develop oligonucleotide and peptide therapeutics on a mission to overcome complex diseases.

TIDE is exploring the boundaries of drug discovery through innovation

Research Details

Details of our research are listed here.

Research Achievements

This page lists our research achievements.
We update and update this page as needed.

Participating Laboratories

Participating laboratories in TMDU are listed.

GREETING from the DIRECTOR

The Nucleotide and Peptide Drug Discovery Center (TIDE Center) at the Institute of Science Tokyo promotes middle molecule drug discovery, focusing on nucleotide and peptide therapeutics. The Center advances convergence science by integrating specialists from diverse fields such as basic medicine, clinical medicine, structural biology, data science, nucleic acid chemistry, peptide chemistry, polymer engineering, pharmacology, pharmacokinetics, toxicology, and pharmaceutical formulation.

Outline

What kind of organization is TIDE " NucleoTIDE and PepTIDE Drug Discovery Center "?
Here is an introduction.

Topics & Information

2025.04.01

New Dr. Kumiko Ui-Tei appointed Director of the TIDE Center.

2024.10.01

Institute of Science Tokyo established following merger of Tokyo Medical and Dental University and Tokyo Institute of Technology.

2023.06.15

NucleoTIDE and PepTIDE Drug Discovery Center (TIDE Center) website is open.